|
| ISN News |
|
|
Membership |
Trainees, Join the ISN for Free or Renew Your Membership
for $15
|
|
|
|
|
|
|
|
EVENTS |
|
Secure Your Spot at WCN'23 in Bangkok, Thailand - Act Now for the Early Bird Offer!
|
|
|
|
|
|
|
|
Grants |
|
 |
New 2022 Mentorship Pairings in the ISN Mentorship Program -
Online Workshop
for 2021 Pairs |
|
 |
| Generous Donation From Renowned Nephrologist's Family Supports ISN Interventional Nephrology Scholar in Peru |
|
|
|
|
RESEARCH |
|
 |
Join Us in Congratulating Four New
ISN-Named Fellows |
|
 |
| Access ISN-ACT Webinar on Hypoxia-inducible Factor-prolyl Hydroxylase Inhibitors |
|
|
|
| Explore the ISN Global Trials Focus Selection for November Featuring ‘Trial of the Month’ on Renin-angiotensin System Inhibition in Advanced Chronic Kidney Disease |
|
|
|
|
|
Advocacy |
|
| The ISN Joins the European Roundtable Discussion on Tackling Inequities in Kidney Care |
|
|
|
|
|
Education/Academy |
|
 |
| Join Us at 6 p.m. on December 16 for the ISN Twitter Space on “Healthy Kidneys for All” |
|
|
|
 |
| “Approach to Diabetic Kidney Disease” - Parts 1 and 2: Watch and Share Two New Modules in the Open-access Curriculum: Online Kidney Education for Primary Care Physicians |
|
 |
|
Thank You to ISN Academy Sponsors Who Helped Us Publish More Than 150 Hours of New Material in 2022
|
|
|
|
|
|
| UPCOMING WEBINARS |
| Wednesday, December 14 I 1 p.m. CET |
ISN Webinar:
Encore Presentation of EMPA-KIDNEY Trial Data
|
|
|
This webinar is supported by an unrestricted educational grant from
|
|
|
|
| Thursday, December 15 I 2 p.m. CET |
ISN Middle East Regional Board Webinar:
Hypertension in the Middle East Region
|
|
|
|
|
|
| |
| RECORDED WEBINARS |
|
| Join or Renew Your Membership here to Access These Webinars |
|
 |
Grand Rounds in Pediatric Nephrology - an ISN-IPNA Sister Centers Initiative:
The Spectrum of Alport Syndrome: Who and How to Investigate?
|
|
|
|
|
|
|
ISN-ISE Webinar
Endocrine and Metabolic Complications After a Kidney Transplant - Part 2
|
|
|
|
|
|
|
ISN-ACT Webinar:
Hypoxia-inducible Factor-prolyl Hydroxylase Inhibitors (HIF-PHIs) 
|
|
|
|
|
|
This webinar is supported by Astellas.
|
|
|
|
|
|
ISN JOURNALS |
|
| COVID-19 |
| Access the Latest ISN Journal Articles on Covid-19 |
|
|
|
|
| KIDNEY INTERNATIONAL EDITORIAL SELECTIONS |
| Urine: From Waste to Fertilizer |
| The authors present the case for recycling urine to recover nutrients for use as fertilizers. This practice would positively impact the environment by decreasing man-made nitrogen compounds and water usage. |
|
The results suggest that PM2.5 is an independent risk factor for kidney failure in patients with IgAN.
|
|
|
|
|
| Implementation Strategies for High-impact Nephrology Trials |
| The authors discuss the apparent lack of implementation – integrating new practices within a setting, and de-implementation – removing low-value, wasteful or harmful treatments from practice, following kidney trials. |
|
To address this deficit, they examine two frameworks that present promising avenues of inquiry for kidney researchers and urge increased evidence uptake after trial publication to benefit the global kidney care community.
|
|
|
|
|
|
| KIDNEY INTERNATIONAL REPORTS EDITORIAL SELECTION |
|
Caring for Australians and New Zealanders With Kidney Impairment Guidelines: Rapid Development of Urate-Lowering Therapy Guidelines for People With Chronic Kidney Disease |
| The Caring for Australians and New Zealanders with Kidney Impairment (CARI) is an evidence-based guideline on urate-lowering therapy in patients with chronic kidney disease (CKD) rapidly produced in response to new clinical trial publications on the topic by the Australian Kidney Trials Network. |
| The result is a strong recommendation against using urate-lowering therapies in those with CKD (not receiving dialysis) and asymptomatic hyperuricemia. |
|
|
|
| |
